WuXi XDC Cayman Inc
2268
Rangering i aksjer
#1886
WuXi XDC Cayman Inc. operates as an investment holding company and a global... WuXi XDC Cayman Inc. operates as an investment holding company and a global contract research, development, and manufacturing organization (CRDMO), with operations spanning China, North America, Europe, and other international regions. The company's expertise covers the entire lifecycle, from discovery and research to development and manufacturing, of biopharmaceutical products. Specifically, it focuses on antibody-drug conjugates (ADCs), various bioconjugates, monoclonal antibody intermediates, and the crucial payload-linkers integral to bioconjugate synthesis. Founded in 2013 and headquartered in Wuxi, China, WuXi XDC Cayman Inc. is a subsidiary of WuXi Biologics (Cayman) Inc.
Aksjekurs
$8.78
Markedsverdi
$11.12B
Endring (1 dag)
-9.52%
Endring (1 år)
0.57%
Land
CN
Handel WuXi XDC Cayman Inc (2268)
Kategori
Healthcare
EPS for WuXi XDC Cayman Inc (2268)
EPS per 2026 TTM: 0
Ifølge de siste økonomiske rapportene og aksjekursen til WuXi XDC Cayman Inc er selskapets nåværende EPS (TTM) 0. Ved slutten av 2026 hadde selskapet en EPS på 0, lik EPS-en i 2026 som var 0.
EPS-historikk for WuXi XDC Cayman Inc fra 2020 til 2026
EPS ved slutten av hvert år
| År | EPS | Endre |
|---|---|---|
| 2025 | $0.17 | 43.07% |
| 2024 | $0.12 | 232.15% |
| 2023 | $0.04 | 95.21% |
| 2022 | $0.02 | 157.53% |
| 2021 | $0.01 | 114.71% |
| 2020 | 0.00 | 0.00% |
EPS for lignende selskaper eller konkurrenter
| Selskap | EPS | EPS-forskjell | Land |
|---|---|---|---|
| $18.99 | - |
US
|
|
| $6.12 | - |
US
|
|
| $-1.36 | - |
US
|
|
| - | - |
CN
|
|
| $5.09 | - |
US
|
